Viewing Study NCT06134232

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:41 PM
Ignite Modification Date: 2026-05-03 @ 3:58 PM
Study NCT ID: NCT06134232
Status: RECRUITING
Last Update Posted: 2025-08-27
First Post: 2023-10-18
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T
Sponsor: Dendreon
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Castration-Resistant Prostate Cancer (mCRPC) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Single Dose View
None Sipuleucel-T View
None Immune Response Rate View
None Safety View
None Adenocarcinoma of the Prostate View